Medical Records

HEPATITIS B PATIENT (JUST BEFORE STARTING TREATMENT)

July 2024- HBsAg Positive

HBV DNA Quantitative – 9360000 IU/ml

LFT – (SGPT- 223 & SGPT- 259)

Anti-HBs – 0.06 (Negative)

Aug 2024- HOO-IMM PLUS-B Treatment Started

After 8 months HOOIMM PLUS-B treatment

HBV DNA Quantitative – 116000 IU/ml

Anti-HBs – 5.46

After 10 months HOOIMM PLUS-B treatment

HBV DNA Quantitative – Target Not Detected

Anti-HBs – 7.57

LFT – (SGPT- 34 & SGPT- 38)

After 12 months HOOIMM PLUS-B treatment

HBV DNA Quantitative – Target Not Detected

HBsAg – Negative

Anti-HBs – 25.8

LUCKAS ONESMO (TANZANIA)

July 2018- HBsAg Positive

Nov 2019- HOO-IMM PLUS-B Treatment Started

Feb 2020 – HBsAg (Positive) & HBV Quantitative – 16000 cp/ml

Oct 2020- HBsAg (Positive) & HBV Quantitative – 158 IU/ml

Dec 2020- HBsAg (Positive) & HBV Quantitative – Target Not Detect

March 2021- HBsAg (Negative) & HBV Quantitative – Target Not Detect

Dec 2021- Anti-HBs

KIRAN KOTIYAN (India)

May 2018- HBsAg Positive & HBV Quantitative – 749820 cp/ml

May 2018- HOO-IMM PLUS-B Treatment Started

Dec 2018- HBsAg (Positive) & HBV Quantitative – 23100 cp/ml

June 2019 – HBV Quantitative – Target Not Detected

June 2019 – HBsAg (Negative)

HEPATITIS B PATIENT 1 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 1 (AFTER 1 MONTH TREATMENT)

HEPATITIS B PATIENT 2 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 2 (AFTER 1 MONTH TREATMENT)

HEPATITIS B PATIENT 3 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 3 (AFTER TREATMENT)

HEPATITIS B PATIENT 5 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 5 (AFTER TREATMENT)

HEPATITIS B PATIENT 5 (AFTER TREATMENT) – Target Not Detected

HEPATITIS B PATIENT 6 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 6 (AFTER 6 MONTHS)

HEPATITIS B PATIENT 7 (JUST BEFORE STARTING TREATMENT)

HEPATITIS B PATIENT 7 (after 40 days treatment with HOOIMM PLUS-B)